Skip to main content
SpringerLink
Log in

The Authors′ Reply

  • Correspondence
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Teml A, Schaeffeler E, Herrlinger KR, et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet 2007; 46: 187–208

    Article  PubMed  CAS  Google Scholar 

  2. Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504–17

    Article  PubMed  Google Scholar 

  3. Mahadevan U, Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 278–82

    Article  PubMed  Google Scholar 

  4. Mahadevan U, Kane S. American Gastroenterological Association Institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology 2006; 131: 283–311

    Article  PubMed  CAS  Google Scholar 

  5. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV. 10. pregnancy in renal transplant recipients. Nephrol Dial Transplant 2002; 17 Suppl. 4: 50–5

    Google Scholar 

  6. Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation. Semin Arthritis Rheum 2005; 35: 112–21

    Article  PubMed  CAS  Google Scholar 

  7. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006; 55: 1198–206

    Article  PubMed  CAS  Google Scholar 

  8. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation. 7th ed. Philadelphia (PA): Lippincott, Williams & Wilkins, 2005

    Google Scholar 

  9. Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118: 705–13

    Article  PubMed  CAS  Google Scholar 

  10. Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord 2003; 3 Suppl. 1: S30–8

    PubMed  Google Scholar 

  11. Kaskas BA, Louis E, Hindorf U, et al. Safe treatment of thiopurine S-methyltransferase deficient Crohn’s disease patients with azathioprine. Gut 2003; 52: 140–2

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, and University of Tübingen, Tübingen, Germany

    Matthias Schwab

  2. Department of Clinical Pharmacology, University Hospital, Tübingen, Germany

    Matthias Schwab

Authors
  1. Matthias Schwab
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwab, M. The Authors′ Reply. Clin Pharmacokinet 46, 805 (2007). https://doi.org/10.2165/00003088-200746090-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-200746090-00008

Keywords

Search

Navigation